首页> 外文OA文献 >DOT1L As a Therapeutic Target for the Treatment of DNMT3A-Mutant Acute Myeloid Leukemia

【2h】

DOT1L As a Therapeutic Target for the Treatment of DNMT3A-Mutant Acute Myeloid Leukemia

机译：DOT1L作为治疗DNMT3A-突变体急性髓性白血病的治疗靶标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rachel E. Rau; Min Luo; Benjamin Rodriguez; Mira Jeong; Allison Rosen; Lishing Deng; Yongcheng Song; Margaret A Goodell;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia [J] . Rau Rachel E., Rodriguez Benjamin A., Luo Min, Blood: The Journal of the American Society of Hematology . 2016,第7期

机译：DOT1L作为治疗DNMT3A突变的急性髓性白血病的治疗靶标
2. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy [J] . Guo Jianfeng, Russell Eileen G., Darcy Raphael, Molecular pharmaceutics . 2017,第3期

机译：抗体靶向环糊精的纳米粒子用于急性髓性白血病治疗中的siRNA递送：物理化学特性，体外机械研究，和患者衍生治疗疗效
3. Divergent Epigenomes in Pediatric and Adult Acute Myeloid Leukemia Implicate Cell of Origin and Transcriptional Silencing of Immune Responses As Sources of Clinically Relevant Heterogeneity: A Report from the Children's Oncology Group and NCI/COG Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative [J] . Triche Timothy Junius Jr., Farrar Jason E., Bolouri Hamid, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：小儿和成人急性髓细胞性白血病的不同表观基因组与临床相关异质性的来源有关，包括起源细胞和免疫应答的转录沉默：儿童肿瘤学组和NCI / COG的报告，这些研究可用于产生有效治疗的研究（TARGET）
4. Characterization of MFC expression in gefitinib versus Acute Myeloid Leukemia reveals novel therapeutic targets [C] . James F. Courage, Saurabh Gupta, Yufeng Wang IEEE International Symposium on Bioinformatics and Bioengineering . 2007

机译：Gefitinib中MFC表达的表征与急性髓性白血病揭示了新的治疗靶标
5. Therapeutic Targeting of the Interleukin 1 Receptor Accessory Protein (IL1 RAP) Reveals Novel Oncogenic Functions in Acute Myeloid Leukemia [D] . Mitchell, Kelly. 2018

机译：白细胞介素1受体辅助蛋白（IL1 RAP）的治疗靶向揭示急性髓细胞白血病中的新型致癌功能。
6. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia [O] . Rachel E. Rau, Benjamin A. Rodriguez, Min Luo, -1

机译：DOT1L作为治疗DNMT3A突变的急性髓性白血病的治疗靶标
7. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia [O] . Rau, Rachel E, Rodriguez, Benjamin A, Luo, Min, 2016

机译：DOT1L作为治疗DNmT3a突变型急性髓性白血病的治疗靶点

DOT1L As a Therapeutic Target for the Treatment of DNMT3A-Mutant Acute Myeloid Leukemia

著录项

引文网络

相似文献

相关主题

期刊订阅